Format

Send to

Choose Destination
J Mol Med (Berl). 2017 Jun;95(6):665-670. doi: 10.1007/s00109-017-1519-3. Epub 2017 Feb 23.

Gain-of-function EGLN1 prolyl hydroxylase (PHD2 D4E:C127S) in combination with EPAS1 (HIF-2α) polymorphism lowers hemoglobin concentration in Tibetan highlanders.

Author information

1
Division of Hematology, University of Utah, Salt Lake City, UT, USA.
2
Department of Pathology and ARUP Laboratories, University of Utah, Salt Lake City, UT, USA.
3
Research Center for High-Altitude Medicine, Qinghai University, Xining, China.
4
Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
5
Departments of Medicine and Obstetrics/Gynecology, University of Colorado Denver, Aurora, CO, USA.
6
MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
7
Department of Molecular Biology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Bratislava, Slovakia.
8
Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India.
9
Regional Centre for Biotechnology, Faridabad, Haryana, India.
10
Division of Hematology, University of Utah, Salt Lake City, UT, USA. josef.prchal@hsc.utah.edu.
11
Department of Pathology and ARUP Laboratories, University of Utah, Salt Lake City, UT, USA. josef.prchal@hsc.utah.edu.
12
Department of Pathophysiology and 1st Department of Medicine, 1st Faculty Medicine, Charles University in Prague, Prague, Czech Republic. josef.prchal@hsc.utah.edu.
13
Hematology, SOM 5C310, University of Utah School of Medicine, Salt Lake City, UT, 84132-2408, USA. josef.prchal@hsc.utah.edu.
14
Research Center for High-Altitude Medicine, Qinghai University, Xining, China. geriligao@hotmail.com.

Abstract

Tibetans have lived at high altitude for generations and are thought to be genetically adapted to hypoxic environments. Most are protected from hypoxia-induced polycythemia, and a haplotype of EPAS1, encoding hypoxia-inducible factor (HIF-2α), has been associated with lower hemoglobin levels. We earlier reported a Tibetan-specific EGLN1 haplotype encoding PHD2 which abrogates HIF augmentation in hypoxia. We genotyped 347 Tibetan individuals from varying altitudes for both the Tibetan-specific EGLN1 haplotype and 10 candidate SNPs in the EPAS1 haplotype and correlated their association with hemoglobin levels. The effect of the EGLN1 haplotype on hemoglobin exhibited age dependency at low altitude, while at higher altitudes, it showed a trend to lower hemoglobin levels in the presence of the Tibetan-selected EPAS1 rs142764723 C/C allele. The observed gene-environment and gene-gene interactions and the moderate effect of the EGLN1 and EPAS1 haplotypes on hemoglobin indicate that other modifiers exist. It remains to be determined whether a blunting of erythropoiesis or other physiological consequences of HIF downregulation are the primary drivers of these genetic adaptations among Tibetans.

KEY MESSAGE:

Most Tibetans are protected from polycythemia while living in high altitude. An EGLN1 co-adapted haplotype, EGLN1 c.12C>G, c.380G>C is uniquely Tibetan. The Tibetan EPAS1 haplotype has introgressed from the Denisovan genome. While EGLN1 and EPAS1 genotypes lower Hb, this study indicates additional Hb modifiers.

KEYWORDS:

Genetic adaptation; High altitude; High-resolution melting assay; Hypoxia; Polycythemia

PMID:
28233034
DOI:
10.1007/s00109-017-1519-3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center